Mounjaro 5mg weight loss reviews: what clinical evidence and patient experience tell us

What SURMOUNT-1 showed about the 5mg dose specifically

The SURMOUNT-1 trial is the foundation most Mounjaro 5mg weight loss reviews should be measured against. It randomised 2,539 adults with obesity across three doses (5mg, 10mg and 15mg) over 72 weeks, alongside a reduced-calorie diet and increased activity. The 5mg group lost an average of around 15% of body weight by the end of the trial. That's roughly 15–16 kg for someone starting at 100 kg, from a single dose level maintained throughout.

Two things are worth understanding about that figure. First, 72 weeks is the full trial duration; weight loss at 5mg accumulates steadily rather than arriving in a single month. Second, in real private prescribing, most people do not stay at 5mg indefinitely, titration continues to 7.5mg, 10mg and beyond if it's clinically appropriate. So the 5mg results partly reflect people who stayed there because the trial required it, rather than moving up. You can read about what happens at the next step in our page covering Mounjaro 7.5mg weight loss outcomes.

NICE reviewed this evidence for its appraisal of tirzepatide (NICE technology appraisal TA1026) and concluded tirzepatide is clinically effective for weight management in appropriate adults, supporting its recommendation for NHS use under specified criteria. The 5mg data formed part of that evidence base.

Why reviews from people at 5mg often read so differently from each other

Browsing Mounjaro 5mg reviews online, you'll notice they can look almost contradictory. One person describes steady losses from week one; another says 5mg felt like nothing for a full month. Both accounts can be accurate. The variation comes from a few sources that online reviews rarely explain clearly.

Starting weight is one factor: a 15% loss lands very differently on different people's bodies, and absolute kilograms lost per week will differ. The 2.5mg starter dose (the pen most people use before moving to 5mg) also does some early work, by the time the 5mg dose begins, appetite suppression may already be established. If you want to understand how people describe that earliest stage before stepping up, you can read what people say about their experience on 2.5mg, and then see how that early period reads in practice on our 2.5mg weight loss review page.

Diet and lifestyle changes alongside treatment also vary enormously between reviewers, and the trial itself required a reduced-calorie diet in all groups. Mounjaro works alongside behavioural change, not instead of it; the NHS tirzepatide medicines page is clear on this point. Someone eating the same as before treatment will see less than the trial figures suggest.

One practical habit worth building: weigh yourself on the same day each week, first thing in the morning, before eating or drinking. A single weekly reading, logged, tells you far more than daily fluctuations and gives your prescriber something reliable to work with at review.

Side effects at 5mg: what to expect and when to take them seriously

The jump from 2.5mg to 5mg is where most people notice the medicine's GI effects most clearly. Nausea is the most commonly reported, followed by loose stools, a reduced urge to eat large amounts, and occasional indigestion or reflux. For the majority of people, these symptoms are at their worst in the first week or two at the new dose and then ease considerably.

That pattern is worth knowing before you read reviews written in week one, they will sound more dramatic than what most people experience at week six. Side effects are real, but the long-term tolerance picture from SURMOUNT-1 is that most participants continued to the full 72 weeks at their assigned dose.

Rare but serious symptoms need prompt attention: severe abdominal pain that spreads to the back could indicate pancreatitis and should not be waited out. If you notice this, seek medical help the same day. For context on safety monitoring in this class of medicines, the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk lets patients report suspected side effects directly.

Oral contraceptives may be less reliably absorbed in the first four weeks at 5mg and for four weeks after each subsequent dose increase, NHS guidance recommends adding a non-oral method during these windows. Discuss this with your prescriber if it applies to you; our FAQs page covers some of the common questions around this.

How 5mg fits into your wider Mounjaro journey

Most private prescribers, and the SmPC itself, treat 5mg as an active therapeutic dose but also as a staging post rather than a destination. The standard titration schedule moves in four-week steps: if 5mg is well tolerated and you'd benefit clinically from a higher dose, the next review considers 7.5mg. There's no obligation to escalate; some people find 5mg suits them well and their prescriber agrees there's no clinical reason to increase.

What you won't find in most Mounjaro 5mg reviews is a clear account of how private prescribers actually manage the journey, because that part happens in clinical consultations, not on forums. At nume, a named prescriber reviews your case before each repeat, not just at the start. There's more on how that process works on our Mounjaro overview page, and if you want to compare how the different doses stack up on the evidence, the 10mg weight loss review page covers the next tier up.

If you're considering treatment and want to understand costs before deciding, our Mounjaro price comparison page sets out what private treatment typically includes. When you're ready to talk to a prescriber, check your eligibility with a free consultation, it's reviewed the same day by a GPhC-registered prescriber, not automated software.